Suppr超能文献

shotgun 蛋白质组学分析揭示了胆固醇酯转移蛋白缺乏症患者高密度脂蛋白中的蛋白质组变化。

Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency.

机构信息

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan; Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry, Osaka, Japan.

出版信息

J Clin Lipidol. 2019 Mar-Apr;13(2):317-325. doi: 10.1016/j.jacl.2019.01.002. Epub 2019 Jan 11.

Abstract

BACKGROUND

We previously reported that the patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) show marked changes in the size and lipid compositions of high-density lipoprotein (HDL) and that they are not protected from atherosclerotic cardiovascular diseases, despite increased serum HDL-cholesterol (HDL-C) levels. HDL particles carry a variety of proteins, some of which are known to have antiatherogenic functions.

OBJECTIVE

This study aimed to investigate the protein composition of HDL particles in patients with CETP-D.

METHODS

Eight patients with complete deficiency of CETP and 8 normolipidemic healthy subjects were enrolled. We performed shotgun proteomic analysis to investigate the proteome of ultracentrifugally isolated HDL.

RESULTS

We identified 79 HDL-associated proteins involved in lipid metabolism, protease inhibition, complement regulation, and acute-phase response, including 5 potential newly identified HDL-associated proteins such as angiopoietin-like3 (ANGPTL3). Spectral counts of apolipoprotein (apo) E were increased in patients with CETP-D compared with controls (60.3 ± 6.9 vs 43.7 ± 2.5, P < .001), which is concordant with our previous report. Complement regulatory proteins such as C3, C4a, C4b, and C9 were also significantly enriched in HDL from patients with CETP-D. Furthermore, apoC-III and ANGPTL3, both of which are now known to associate with increased atherosclerotic cardiovascular diseases, were enriched in patients with CETP-D compared with normolipidemic subjects (35.9 ± 5.3 vs 27.1 ± 3.7, 2.3 ± 1.1 vs 0.4 ± 1.1, respectively; P < .01).

CONCLUSION

We have characterized HDL-associated proteins in patients with CETP-D. We identified a significant increase in the amount of apoE, apoC-III, ANGPTL3, and complement regulatory proteins. These proteomic changes might be partly responsible for the enhanced atherogenicity of patients with CETP-D.

摘要

背景

我们之前曾报道过,胆固醇酯转移蛋白(CETP)缺乏症(CETP-D)患者的高密度脂蛋白(HDL)大小和脂质组成发生明显变化,尽管血清 HDL-胆固醇(HDL-C)水平升高,但他们仍不能预防动脉粥样硬化性心血管疾病。HDL 颗粒携带多种蛋白质,其中一些已知具有抗动脉粥样硬化作用。

目的

本研究旨在研究 CETP-D 患者 HDL 颗粒的蛋白质组成。

方法

纳入 8 例完全缺乏 CETP 的患者和 8 例血脂正常的健康对照者。我们进行了鸟枪法蛋白质组学分析,以研究超速离心分离的 HDL 的蛋白质组。

结果

我们鉴定出 79 种与脂质代谢、蛋白酶抑制、补体调节和急性期反应相关的 HDL 相关蛋白,包括 5 种潜在的新发现的 HDL 相关蛋白,如血管生成素样蛋白 3(ANGPTL3)。与对照组相比,CETP-D 患者的载脂蛋白(apo)E 谱计数增加(60.3±6.9 对 43.7±2.5,P<.001),这与我们之前的报告一致。补体调节蛋白如 C3、C4a、C4b 和 C9 也在 CETP-D 患者的 HDL 中明显富集。此外,apoC-III 和 ANGPTL3 与动脉粥样硬化性心血管疾病的风险增加有关,与血脂正常的受试者相比,这两种蛋白在 CETP-D 患者中也明显富集(35.9±5.3 对 27.1±3.7,2.3±1.1 对 0.4±1.1,P<.01)。

结论

我们对 CETP-D 患者的 HDL 相关蛋白进行了特征描述。我们发现 apoE、apoC-III、ANGPTL3 和补体调节蛋白的含量显著增加。这些蛋白质组学变化可能部分解释了 CETP-D 患者的促动脉粥样硬化作用增强的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验